NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Stock Ownership - Who owns Cyclacel Pharmaceuticals?

Insider buying vs selling

Have Cyclacel Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David E. LazarInterim CEO2025-02-26194,628,820$0.03
$5.45MSell

1 of 1

CYCC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCC insiders and whales buy or sell their stock.

CYCC Shareholders

What type of owners hold Cyclacel Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wong Sing Ee Doris873.86%194,628,820$65.78MInsider
Austin W. Greenhouse David M. Marxe12.60%2,806,900$948.73kInsider
Stanley Morgan10.22%2,276,852$769.58kInsider
James E. Flynn6.22%1,385,091$468.16kInsider
Armistice Capital LLC5.70%1,269,485$429.09kInstitution
Kevin C. Tang1.91%425,700$143.89kInsider
Kok Hui Tan1.12%250,000$84.50kInsider
Sukses Engineering Sdn Bhd Suria1.12%250,000$84.50kInsider
Kee Wee Ho1.12%250,000$84.50kInsider
Jien Shiung Ho1.12%250,000$84.50kInsider

1 of 3

CYCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCC0.79%99.21%Net Selling
CHRO9.03%54.19%Net Buying
NLSP5.36%0.00%
CVM25.29%74.71%Net BuyingNet Buying
GNPX1.38%18.35%Net Selling

Cyclacel Pharmaceuticals Stock Ownership FAQ

Who owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals (NASDAQ: CYCC) is owned by 7.30% institutional shareholders, 912.15% Cyclacel Pharmaceuticals insiders, and 0.00% retail investors. Wong Sing Ee Doris is the largest individual Cyclacel Pharmaceuticals shareholder, owning 194.63M shares representing 873.86% of the company. Wong Sing Ee Doris's Cyclacel Pharmaceuticals shares are currently valued at $66.37M.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.